HomeCompareIBRN vs NOBL

IBRN vs NOBL: Dividend Comparison 2026

IBRN yields 0.97% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOBL wins by $1.8K in total portfolio value
10 years
IBRN
IBRN
● Live price
0.97%
Share price
$32.96
Annual div
$0.32
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.1K
Annual income
$103.34
Full IBRN calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — IBRN vs NOBL

📍 NOBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBRNNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBRN + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBRN pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBRN
Annual income on $10K today (after 15% tax)
$82.48/yr
After 10yr DRIP, annual income (after tax)
$87.84/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, NOBL beats the other by $124.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBRN + NOBL for your $10,000?

IBRN: 50%NOBL: 50%
100% NOBL50/50100% IBRN
Portfolio after 10yr
$22.0K
Annual income
$176.56/yr
Blended yield
0.80%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBRN buys
0
NOBL buys
0
No recent congressional trades found for IBRN or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBRNNOBL
Forward yield0.97%2.17%
Annual dividend / share$0.32$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$21.1K$22.9K
Annual income after 10y$103.34$249.78
Total dividends collected$1.0K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: IBRN vs NOBL ($10,000, DRIP)

YearIBRN PortfolioIBRN Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$10,797$97.03$10,917$217.08$120.00NOBL
2$11,651$97.91$11,903$221.48$252.00NOBL
3$12,565$98.74$12,962$225.68$397.00NOBL
4$13,544$99.52$14,099$229.68$555.00NOBL
5$14,592$100.26$15,319$233.49$727.00NOBL
6$15,715$100.95$16,628$237.10$913.00NOBL
7$16,917$101.61$18,033$240.53$1.1KNOBL
8$18,203$102.22$19,539$243.78$1.3KNOBL
9$19,580$102.80$21,154$246.86$1.6KNOBL
10$21,054$103.34$22,884$249.78$1.8KNOBL

IBRN vs NOBL: Complete Analysis 2026

IBRNStock

The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.

Full IBRN Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this IBRN vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBRN vs SCHDIBRN vs JEPIIBRN vs OIBRN vs KOIBRN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.